CIOs, CTOs want to fill These Five Roles ASAP
A survey by recruitment agency Robert Half revealed that CIOs and CTOs are looking to meet the increased demand for specialist technology and digital skills across different business sectors.
The five most important technology roles CIOs and CTOs are looking for in the second half of 2021 are cloud engineers, front-end developers, business transformation specialists, database administrators, and business intelligence specialists, the report found.
In terms of specialist skills, Robert Half recorded a substantial uptick in demand for DevOps (319%), Software as a Service (SaaS) skills (143%) and Python programming (137%).
71% Employees Say Excess Tools Making Work Complex and Breaking User Experience
Technology implemented to keep employees engaged and productive is frustrating and slowing them down. According to a new study from Citrix Systems, employees feel they’ve been given too many tools and not enough efficient ways to execute. And it’s hindering their ability to get things done.
Citrix undertook Work Your Way, a survey of 1,000 IT decision makers and 2,000 workers across the United States conducted by OnePoll, which revealed a few significant trends:
The number of tools employees are required to use to do their jobs has significantly increased, as has the complexity they are creating in the workplace. As uncovered by the survey:
- 64 percent of workers are using more communication and collaboration tools than they were prior to the pandemic, and
- 71 percent say they have made work more complex.
Employees are frustrated, and to keep them engaged and performing at their best, companies need to eliminate the friction and noise from work and deliver technology that adapts to their workstyles rather than forcing them to learn new ways of doing things.
PharmEasy to Acquire Majority Stake in Thyrocare
In a first ever acquisition of a listed company by a startup unicorn, online pharmacy startup PharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies as it looks to diversify and bolster its testing business. PharmEasy has signed a definitive agreement to acquire a 66.1 percent stake in Thyrocare for Rs 4,546 crore, according to an exchange filing made on Friday, the first acquisition of a listed company by an Indian unicorn.
PharmEasy will retain the Thyrocare brand. The acquisition gives PharmEasy a much needed offline presence in diagnostics through a network of over 3,300 collection centers in 2,000 Indian towns. Thyrocare is India’s leading diagnostics solution provider by volume with more than 110 million tests performed annually.
